Citations

Mayo Clinic

Showing 10 of 108599 citations.

Outcomes of asymptomatic histologic pyelonephritis of kidney transplant
Budhiraja, Pooja , Butterfield, Richard , Gea‐Banacloche, Juan , Swaminathan, Sundararaman , Khamash, Hassan A., Me, Hay Me , Kodali, Lavanya , Nair, S. , Misra, Suman , Heilman, Raymond L. , Mour, Girish K., Nair, Sumi, Heilman, Raymond , Budhiraja, Pooja , Smith, Maxwell L. , Mour, Girish

Clinical Transplantation | September 14, 2023 | Volume: 37 | Issue: 12 | Pages: No page available

10.1111/ctr.15125 | PMID 37705388 Get It

AbstractBackgroundUrinary Tract Infections are the most common post‐transplant infection and can have varied presentations. This study aimed to describe the outcomes of kidney transplant recipients with asymptomatic histologic pyelonephritis on allograft biopsy. Histologic Pyelonephritis was defined as neutrophil cast or neutrophilic tubulitis, interstitial infiltrates with predominant neutrophils, and no evidence of rejection or glomerulonephritis on biopsy.MethodsThe study included 123 kidney transplant recipients, of whom 95 underwent protocol biopsies, and 28 had biopsies for elevated creatinine within the first 2 years of a kidney transplant.ResultsThe mean age of the cohort was 55.3 years, with 52% females and 78% deceased donor transplants. The risk factors for asymptomatic histologic pyelonephritis were recipient female sex (OR 1.89, 1.3–2.7, diabetes mellitus (OR 2.479, 1.687–3.645), and deceased donation (OR 1.69, 1.098–2.63). The incidence of asymptomatic pyelonephritis on protocol biopsy was 1.7%, with 52% having positive urine cultures and Escherichia coli being the most common bacteria. Subjects with asymptomatic pyelonephritis had inferior graft survival compared to the matched cohort HR 1.88 (1.06–3.35), p = .0281. In addition, of these 123 subjects, 68 (55%) subsequently developed pyelonephritis, and 34 subjects had pyelonephritis within 6 months after this episode. Subjects with recurrent infections exhibited lower survival HR 2.86 (1.36–6.02) and a trend toward higher rejection risk.ConclusionAsymptomatic histologic pyelonephritis can occur in kidney transplant recipients and is associated with inferior graft survival.
BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas–kidney recipients
Kudva, Yogish C. , Seville, Maria Teresa , Bosch, Wendelyn , Dean, Patrick G. , Huskey, Janna L. , Budhiraja, Pooja , Jarmi, Tambi , Kukla, Aleksandra , Beam, Elena , Kudva, Yogish C. , Budhiraja, Pooja , Jarmi, Tambi , Kukla, Aleksandra , Beam, Elena , Yetmar, Zachary A.

Clinical Transplantation | September 14, 2023 | Volume: 37 | Issue: 11 | Pages: No page available

10.1111/ctr.15135 | PMID 37705389 Get It

AbstractBackgroundBK polyomavirus (BKV) infection is a common complication of kidney transplantation. While BKV has been described in non‐kidney transplant recipients, data are limited regarding its epidemiology and outcomes in pancreas transplant recipients.MethodsWe conducted a retrospective cohort study of adults who underwent pancreas transplantation from 2010–2020. The primary outcome was BKV DNAemia. Secondary outcomes were estimated glomerular filtration rate (eGFR) reduction by 30%, eGFR < 30 mL/min/1.73 m2, endstage kidney disease, and pancreas allograft failure. Cox regression with time‐dependent variables was utilized.ResultsFour hundred and sixty‐six patients were analyzed, including 74, 46, and 346 with pancreas transplant alone (PTA), pancreas‐after‐kidney, or simultaneous pancreas–kidney transplants, respectively. PTA recipients experienced a lower incidence of BKV DNAemia (8.8% vs. 32.9%; p < .001) and shorter duration of DNAemia (median 28.0 vs. 84.5 days). No PTA recipients with BKV DNAemia underwent kidney biopsy or developed endstage kidney disease. Lymphopenia, non‐PTA transplantation, and older age were associated with BKV DNAemia, which itself was associated with pancreas allograft failure (adjusted hazard ratio 2.14, 95% confidence interval 1.27–3.60; p = .004). Among PTA recipients, BKV DNAemia was not associated with eGFR reduction or eGFR < 30 mL/min/1.73 m2.ConclusionsBKV DNAemia was common among PTA recipients, though lower than a comparable group of pancreas–kidney recipients. However, BKV DNAemia was not associated with adverse native kidney outcomes and no PTA recipients developed endstage kidney disease. Conversely, BKV DNAemia was associated with pancreas allograft failure. Further studies are needed to estimate the rate of BKV nephropathy in this population, and further evaluate long‐term kidney outcomes.
Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies
Chlon, Timothy M. , Patnaik, Mrinal M. , Chlon, Timothy M.

American Journal of Hematology | September 14, 2023 | Volume: 98 | Issue: 11 | Pages: 1673-1676

10.1002/ajh.27091 | PMID 37705260 Get It

Disparities in Offering Enrollment in Remote Patient Monitoring for COVID-19
Thompson, Joshua A. , Hersch, Derek , Kasozi, Ramla N. , Miner, Michael H. , Adam, Patricia

Telemedicine and e-Health | September 14, 2023 | Volume: 30 | Issue: 3 | Pages: 715-721

10.1089/tmj.2023.0150 | PMID 37707989 Get It

Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis
Jalan‐Sakrikar, Nidhi , Anwar, Abid , Yaqoob, Usman , Gan, Can, Lagnado, Anthony B. , Wixom, Alexander Q. , Jurk, Diana , Huebert, Robert C. , Huebert, Robert , Jurk, Diana , Sakrikar, Nidhi Jalan , Wixom, Alexander Q , Yaqoob, Usman

JCI Insight | September 14, 2023 | Volume: 8 | Issue: 20 | Pages: No page available

10.1172/jci.insight.170320 | PMID 37707950 Get It

Cellular senescence and biliary fibrosis are prototypical features of obliterative cholangiopathies, such as primary sclerosing cholangitis (PSC). Telomere dysfunction can lead to senescence either through telomere erosion or damaged telomeres. Our goal was to investigate a mechanistic relationship between telomere damage and biliary fibrosis in PSC. Telomere attrition was observed in the bile ducts of patients with PSC along with a reduction in telomerase reverse transcriptase (TERT) expression, compared with that in normal livers. Similarly, liver tissue from mouse models of biliary fibrosis showed telomere attrition with increased damage at telomeres measured as telomere-associated foci (TAF). Cellular models of senescence induction increased the TAF in cholangiocytes. This coincided with decreased TERT expression and increased senescence, which was rescued by modulating TERT levels. Epigenetic analysis revealed increased acquisition of repressive histone methylation at the TERT promoter, which correlated with decreased TERT transcription. Cholangiocyte-selective deletion of TERT in mice exacerbated fibrosis, whereas androgen therapy toward telomerase rescued liver fibrosis and liver function in a genetic mouse model of PSC. Our results demonstrate a mechanistic role for telomere dysfunction in cellular senescence and fibrosis that characterize PSC. This suggests that PSC may be, in part, a telomere biology disorder, and identifies TERT as a potential therapeutic target.
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening
Nosheny, Rachel L. , Yen, Daniel , Howell, Taylor, Camacho, Monica R. , Moulder, Krista L., Gummadi, Shilpa, Bui, Chau, Kannan, Sandhya, Ashford, Miriam T. , Knight, Kristen, Mayo, Connie, McMillan, M. G., Petersen, Ronald C. , Roberson, Erik D. , Chambless, Carol, Gersteneker, Adam, Martin, Roy C. , Kennedy, Richard , Kukull, Walter A. , Flenniken, Derek , Fockler, Juliet , Truran, Diana , Mackin, R. Scott , Weiner, Michael W. , Morris, John C. , Li, Yan , Stricker, Nikki H. , Roberson, Erik , Kennedy, Richard E , Morris, John C , McMillan, Maureen, Zhang, Yue

JAMA Network Open | September 14, 2023 | Volume: 6 | Issue: 9 | Pages: e2333786

10.1001/jamanetworkopen.2023.33786 | PMID 37707812 Get It

Importance The Clinical Dementia Rating (CDR) is a well-validated instrument widely used to detect and stage dementia due to Alzheimer disease. The digital Electronic Clinical Dementia Rating (eCDR) can be remotely self-administered and automatically scored, with potential to facilitate efficient dementia screening and staging. Objective To evaluate the association of the eCDR with the CDR and other in-clinic assessments for screening older adults for cognitive impairment. Design, Setting, and Participants This multisite, cross-sectional study used baseline data from a longitudinal, observational study from 2020 to 2023, including up to 3 years of follow-up. Participants were enrolled from 3 Alzheimer Disease Research Centers and the Brain Health Registry. Participants (aged ≥55 years, with a study partner, and no acute or unstable major medical conditions) were recruited during in-clinic visits or by automated emails. Exposures Participants completed the Uniform Data Set Version 3 (UDS; including the CDR) in supervised clinical research settings, and then completed the eCDR remotely, online and unsupervised, using their own device. Main Outcomes and Measures The primary outcomes were eCDR scores (item; categorical box and global; continuous box and global), CDR scores (item; categorical box and global), and UDS assessment scores. Associations were evaluated using linear and logistic regressions. Results A total of 3565 participants were contacted, and 288 were enrolled. Among 173 participants with item-level data (mean [SD] age, 70.84 [7.65] years; 76 women [43.9%]), eCDR to CDR concordance was 90% or higher for 33 items (63%) and 70% to 89% for 13 items (25%). Box (domain) level concordance ranged from 80% (memory) to 99% (personal care). The global score concordance rate was 81%. κ statistics were fair to moderate. Among 206 participants with box and global scores (mean [SD] age, 71.34 [7.68] years; 95 women [46.1%]), eCDR continuous global score was associated with CDR global (categorical) score with an area under the receiver operating characteristic curve of 0.79 (95% CI, 0.70-0.87). Correlations between eCDR and in-clinic UDS assessments were similar to those between CDR sum of box scores and the same in-clinic assessments. Conclusions and Relevance These findings suggest that the eCDR is valid and has potential use for screening and assessment of older adults for cognitive and functional decline related to Alzheimer disease. Instrument optimization and validation in diverse cohorts in remote settings are crucial for evaluating scalability and eCDR utility in clinical research, trials, and health care settings.
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial
Swisher, Elizabeth M. , Rayes, Nadine , Peterson, Christine B. , Norquist, Barbara M. , Coffin, Tara B. , Gavin, Kathleen , Polinsky, Deborah , Crase, Jamie , Blank, Stephanie V. , Olopade, Olufunmilayo I. , Law, Sherman , D’Andrea, Alan D. , Lu, Karen H. , Olopade, Olufunmilayo I , Swisher, Elizabeth M , Peterson, Christine , Norquist, Barbara , D'Andrea, Alan , Bowen, Deborah J. , Bakkum‐Gamez, Jamie N. , Munsell, Mark F. , Nebgen, Denise R. , Fleming, Gini F. , Zhou, Alicia Yiran , Levine, Douglas A.

JAMA Oncology | September 14, 2023 | Volume: 9 | Issue: 11 | Pages: 1547

10.1001/jamaoncol.2023.3748 | PMID 37707822 Get It

Importance Requiring personalized genetic counseling may introduce barriers to cancer risk assessment, but it is unknown whether omitting counseling could increase distress. Objective To assess whether omitting pretest and/or posttest genetic counseling would increase distress during remote testing. Design, Setting, and Participants Making Genetic Testing Accessible (MAGENTA) was a 4-arm, randomized noninferiority trial testing the effects of individualized pretest and/or posttest genetic counseling on participant distress 3 and 12 months posttest. Participants were recruited via social and traditional media, and enrollment occurred between April 27, 2017, and September 29, 2020. Participants were women aged 30 years or older, English-speaking, US residents, and had access to the internet and a health care professional. Previous cancer genetic testing or counseling was exclusionary. In the family history cohort, participants had a personal or family history of breast or ovarian cancer. In the familial pathogenic variant (PV) cohort, participants reported 1 biological relative with a PV in an actionable cancer susceptibility gene. Data analysis was performed between December 13, 2020, and May 31, 2023. Intervention Participants completed baseline questionnaires, watched an educational video, and were randomized to 1 of 4 arms: the control arm with pretest and/or posttest genetic counseling, or 1 of 3 study arms without pretest and posttest counseling. Genetic counseling was provided by phone appointments and testing was done using home-delivered saliva kits. Main Outcomes and Measures The primary outcome was participant distress measured by the Impact of Event Scale 3 months after receiving the results. Secondary outcomes included completion of testing, anxiety, depression, and decisional regret. Results A total of 3839 women (median age, 44 years [range 22-91 years]), most of whom were non-Hispanic White and college educated, were randomized, 3125 in the family history and 714 in the familial PV cohorts. In the primary analysis in the family history cohort, all experimental arms were noninferior for distress at 3 months. There were no statistically significant differences in anxiety, depression, or decisional regret at 3 months. The highest completion rates were seen in the 2 arms without pretest counseling. Conclusions and Relevance In the MAGENTA clinical trial, omitting individualized pretest counseling for all participants and posttest counseling for those without PV during remote genetic testing was not inferior with regard to posttest distress, providing an alternative care model for genetic risk assessment. Trial Registration ClinicalTrials.gov Identifier: NCT02993068
Effect of Infraorbital and/or Infratrochlear Nerve Blocks on Postoperative Care in Patients with Septorhinoplasty: A Meta-Analysis
Kim, Do Hyun , Park, Jun‐Beom , Kim, Sung Won , Stybayeva, Gulnaz , Hwang, Se Hwan , Stybayeya, Gulnaz , Kim, Do Hyun , Hwang, Se Hwan

Medicina | September 14, 2023 | Volume: 59 | Issue: 9 | Pages: 1659

10.3390/medicina59091659 | PMID 37763778 Get It

Background and Objectives: Through a comprehensive meta-analysis of the pertinent literature, this study evaluated the utility and efficacy of perioperative infraorbital and/or infratrochlear nerve blocks in reducing postoperative pain and related morbidities in patients undergoing septorhinoplasty. Materials and Methods: We reviewed studies retrieved from the PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to August 2023. The analysis included a selection of seven articles that compared a treatment group receiving perioperative infraorbital and/or infratrochlear nerve blocks with a control group that either received a placebo or no treatment. The evaluated outcomes covered parameters such as postoperative pain, the amount and frequency of analgesic medication administration, the incidence of postoperative nausea and vomiting, as well as the manifestation of emergence agitation. Results: The treatment group displayed a significant reduction in postoperative pain (mean difference = −1.7236 [−2.6825; −0.7646], I2 = 98.8%), as well as a significant decrease in both the amount (standardized mean difference = −2.4629 [−3.8042; −1.1216], I2 = 93.0%) and frequency (odds ratio = 0.3584 [0.1383; 0.9287], I2 = 59.7%) of analgesic medication use compared to the control. The incidence of emergence agitation (odds ratio = 0.2040 [0.0907; 0.4590], I2 = 0.0%) was notably lower in the treatment group. The incidence of postoperative nausea and vomiting (odds ratio = 0.5393 [0.1309; 2.2218], I2 = 60.4%) showed a trend towards reduction, although it was not statistically significant. While no adverse effects reaching statistical significance were reported in the analyzed studies, hematoma (proportional rate = 0.2133 [0.0905; 0.4250], I2 = 76.9%) and edema (proportional rate = 0.1935 [0.1048; 0.3296], I2 = 57.2%) after blocks appeared at rates of approximately 20%. Conclusions: Infraorbital and/or infratrochlear nerve blocks for septorhinoplasty effectively reduce postoperative pain and emergence agitation without notable adverse outcomes.
Mental health and psychiatry: Distinctions, links, and ethical/bioethical perspectives
Wagner-Grau, Patrick, Perales, Alberto , Alarcón, Renato D.

Salud mental | September 14, 2023 | Volume: 46 | Issue: 5 | Pages: 231-240

10.17711/sm.0185-3325.2023.029 Get It

Introduction. Mental health and psychiatry have been terms of intense and complex use for almost a century, and they may have reached a critical level of ambiguous and imprecise synonymy that makes their definition and validation difficult. Objective. To examine these concepts in depth, establishing precise distinctions, ontological connections, and instrumental scope reinforced by well-defined ideas in ethics and bioethics. Method. Narrative review of pertinent literature, consultation with diverse scientific, medical, historical, philosophical, and literary sources, with appropriate analysis of ethical and bioethical practices. Results. A broad, comprehensive definition is elaborated of mental health as a field with sociocultural, political, and demographic implications, and of psychiatry as a medical specialty. In addition to making clear distinctions and describing the specific impact of both fields on diverse populations, various levels of conceptual linkages, sociopolitical action, and ethical content are highlighted, as well as in processes of administration, education, and research. Discussion and conclusion. There are factors that reinforce or weaken the scope of mental health and psychiatry, including their ethical and bioethical dimensions. Their effectiveness requires a reaffirmation of objectives and the reinforcement of individual and institutional initiatives, as well as the search for authentic connections and a social projection that is objective, comprehensive, and just.
Investigation of scan path optimization in improving proton pencil beam scanning continuous delivery
Liu, Chunbo , Beltran, Chris , Park, Chunjoo, Yaddanapudi, Sridhar , Tan, Jun , Furutani, Keith M. , Liang, Xiaoying , Tan, Jun , Shen, Jiajian , Furutani, Keith M , Liang, Xiaoying , Beltran, Chris J , Yaddanapudi, Sridhar , Shen, Jiajian , Lu, Bo, Tan, Jun

Physics in Medicine & Biology | September 13, 2023 | Volume: 68 | Issue: 19 | Pages: 195023

10.1088/1361-6560/acf98e | PMID 37703907 Get It

Abstract Objective . To investigate the impact of scan path optimization on the dose accuracy and beam delivery time (BDT) of proton pencil beam scanning in the dose-driven continuous scanning (DDCS). Approach . A diverse set of six clinical plans, representing various spot patterns and treatment sites, was used to evaluate the effectiveness of scan time optimization and scan length optimization. The DDCS dose discrepancy and BDT with optimized scan paths was compared to the default serpentine scan path. Main results . Both scan time optimization and scan path optimization were able to reduce the DDCS dose discrepancy compared to the default serpentine scan path. All plans, except for the layer repainting lung plan, achieved a 2%/2 mm gamma pass rate of over 99% and less than 1% PTV DVH root mean square error (RMSE) through scan path optimization. In the case of the layer repainting lung plan, when compared to the default serpentine scan path, the 2%/2 mm gamma pass rate showed improvements from 91.3% to 93.1% and 95.8%, while the PTV DVH RMSE decreased from 2.1% to 1.7% and 1.1% for scan time optimization and scan length optimization, respectively. Although scan time optimization resulted in shorter total scan times for all plans compared to the default scan path and scan length optimization tended to have longer total scan times. However, due to the short total scan times and their minimal contribution to the total BDT, the impact of scan path optimization on the total BDT was practically negligible. Significance . Both scan time optimization and scan length optimization proved to be effective in minimizing DDCS dose discrepancy. No definitive winner can be determined between these two optimization approaches. Both scan time and scan length optimization had minimal effect on the total BDT.